CHANEX

Oxford BioMedica plc

Application Filed: 1998-09-24

Trademark Application Details

Mark For: CHANEX® trademark registration is intended to cover the categories of clinical, medical reagents for use in the gene therapy; pharmaceutical preparations for use in gene therapy; Therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acids for gene therapy; pharmaceutical preparations containing nucleic acid for use in the treatment of cancer, HIV and AIDS related infections and bodily conditions associated with impaired immunosystems; viral and bacterial diseases, cancer and cystic fibrosis, pharmaceutic preparations in the field of gene therapy, pharmaceutics preparations for the treatment of cystic fibrosis.

Status

2021-07-25 UTC

DEAD REGISTRATION Cancelled Invalidated

The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.

Research	OneLook Acronym Finder
Serial Number	75559264
Registration Number	2437902
Mark Literal Elements	CHANEX
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	Trademark
Standard Character Claim	No
Current Location	SCANNING ON DEMAND 2006-11-22
Basis	44(e)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	Yes
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Domestic Representative	Donald N. Huff
Attorney Name	Donald N. Huff
Law Office Assigned	L50
Employee Name	DALIER, JOHN DAVID

Timeline

1998-09-24	Application Filed
2001-01-02	Published
2001-01-02	Published for Opposition
2001-03-27	Trademark Registered
2006-11-22	Location: SCANNING ON DEMAND
2007-12-29	Cancelled
2007-12-29	Status: Dead/Cancelled
2007-12-29	Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	Oxford BioMedica plc
Address	Medawar Centre Robert Robinson Avenue The Oxford Science Park Oxford, OX4 4GA UNITED KINGDOM
Legal Entity Type	Corporation
Legal Entity State	UNITED KINGDOM

Documents

Registration Certificate	TIFF	2001-03-27
Registration Certificate	TIFF	2001-03-27
Paper Correspondence Incoming	TIFF	2001-04-24
Change of Address	TIFF	2003-07-16
File Jacket	JPEG	2006-11-14
Unclassified	TIFF	2006-11-14

Attorney of Record

Donald N. Huff
Dykema Gossett, PLLC
Suite 300 West
1300 I Street, NW
Washington DC 20005

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	10
U.S. Codes:	026,039,044

Type Code	Type
GS0051	Clinical, medical reagents for use in the gene therapy; pharmaceutical preparations for use in gene therapy; Therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acids for gene therapy; pharmaceutical preparations containing nucleic acid for use in the treatment of cancer, HIV and AIDS related infections and bodily conditions associated with impaired immunosystems; viral and bacterial diseases, cancer and cystic fibrosis, pharmaceutic preparations in the field of gene therapy, pharmaceutics preparations for the treatment of cystic fibrosis

Type Code

Type

GS0051

Clinical, medical reagents for use in the gene therapy; pharmaceutical preparations for use in gene therapy; Therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acids for gene therapy; pharmaceutical preparations containing nucleic acid for use in the treatment of cancer, HIV and AIDS related infections and bodily conditions associated with impaired immunosystems; viral and bacterial diseases, cancer and cystic fibrosis, pharmaceutic preparations in the field of gene therapy, pharmaceutics preparations for the treatment of cystic fibrosis

Trademark Filing History

Description	Date	Proceeding Number
CANCELLED SEC. 8 (6-YR)	2007-12-29
CASE FILE IN TICRS	2006-11-22
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2003-07-16
REGISTERED-PRINCIPAL REGISTER	2001-03-27
PUBLISHED FOR OPPOSITION	2001-01-02
NOTICE OF PUBLICATION	2000-12-01
APPROVED FOR PUB - PRINCIPAL REGISTER	2000-08-20
CORRESPONDENCE RECEIVED IN LAW OFFICE	2000-05-24
FINAL REFUSAL MAILED	1999-11-24
CORRESPONDENCE RECEIVED IN LAW OFFICE	1999-09-29
NON-FINAL ACTION MAILED	1999-05-10
ASSIGNED TO EXAMINER	1999-05-10	72503
ASSIGNED TO EXAMINER	1999-04-27	76625

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
CHANEX 88556760 not registered Live/Pending	Tinka (Shanghai) Trading Co., Ltd 2019-08-01
CHANEX 77116990 3408109 Dead/Cancelled	OXFORD BIOMEDICA PLC 2007-02-27
CHANEX 75559264 2437902 Dead/Cancelled	Oxford BioMedica plc 1998-09-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.